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T cells activate the tumor necrosis factor-a system during he- Patients on chronic hemodialysis (HD) suffer from
modialysis, resulting in tachyphylaxis. general immunosuppression, leading to a high suscepti-
Background. The immunosuppressive state of hemodialysis bility for infection and cancer, and show a deficient re-
(HD) patients is accompanied by activation of antigen-present-
sponse on T-cell–dependent antigens, like hepatitis Bing cell-derived cytokines, for example, tumor necrosis fac-
and influenza vaccination [1, 2].tor-a (TNF-a), which are required for T-cell activation. To test
whether an activated TNF-a system results in impaired T-cell This depression of T-cell activity might be the result
response in these patients, we analyzed parameters of their of a defect in their antigen-presenting cell (APC) func-
antigen-presenting cell (APC) function (for example, TNF-a tion, in which the proinflammatory cytokine tumor ne-
system) and T-cell function [for example, interleukin-2 (IL-2)
crosis factor-a (TNF-a) plays a prominent role. How-system].
ever, the immunusuppressive state of HD patients seemsMethods. By quantitative flow cytometry, the expression of
to be accompanied by activation rather than by impair-the TNF-receptor 2 (TNF-R2 5 CD120b) and the a and b chain
of the IL-2 receptor (IL-2R; CD25, CD122) was measured. ment of the monocyte/macrophage system, resulting in
Using reverse transcriptase-polymerase chain reaction, the an increased production of cytokines, such as TNF-a,
mRNA for TNF-a, IL-2, and IL-2R were determined. Phyto- interleukin-1b (IL-1b), and IL-6 [3–6]. Therefore, factorshemagglutinin (PHA)- and IL-2–stimulated proliferation and
other than the TNF-a system might be involved in thecytokine production were measured. Biological activity of solu-
immune compromised state of HD patients, for example,ble receptors was measured by adding recombinant cytokines
to the patient’s plasma. an intrinsic defect of T cells to produce and to respond
Results. CD120b expression was significantly increased in to IL-2. IL-2 promotes expansion of T cells, augments
HD patients, whereas CD25 and CD122 was comparable to the cytolytic activity of natural killer (NK) cells, is in-
controls. In contrast to mRNA for IL-2 and IL-2R, mRNA volved in the synthesis of immunoglobulins by B cells,for TNF-a was increased in HD. This resulted in significantly
and protects activated T cells from apoptosis [7–9]. Im-increased TNF-a levels in HD patients. In peripheral blood of
mune reactivity in vivo, however, is not only determinedHD patients, high levels of soluble TNF-R (R1 and R2) and
IL-2R were found. These receptors were capable of binding by cytokine production, but also depends on the presence
40% of added TNF-a and 55% of added IL-2. PHA-induced and activity of their antagonists, and thus on the bio-
TNF-a production by T cells from HD patients was significantly availibility of cytokines. Biological activity of cytokines
lower, while their PHA-stimulated IL-2 production and prolif-
is regulated by membrane-bound receptors. For TNF-a,eration capacity by T cells were comparable to controls.
two receptors have been identified, R1 (p55) and R2Conclusions. We conclude that although the TNF-a system
(p75), while IL-2 has its own IL-2R consisting of threeis activated during HD, the TNF-a production of T cells is
impaired, suggesting that tachyphylaxis of T cells occurs for separate chains, IL-2Ra (CD25), IL-2Rb (CD122), and
TNF-a, as their proliferative capacity and IL-2 production ca- IL-2Rg (CD132) chain. After binding, the extracellular
pacity do not imply an intrinsic T-cell defect. domain of the receptor splits off and can be identified
as soluble receptors: sTNF-R1, sTNF-R2, and sIL-2R
[9, 10]. These soluble receptors are mainly metabolized
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by renal clearance. However, their molecular weight pre-senting cell, renal replacement therapy, renal clearance, peripheral
blood, uremia. vents clearance by the dialyzer membrane. Recently, we
found high levels of sTNF-R1 and sTNF-R2 in peripheralReceived for publication November 22, 1999
blood of patients on renal replacement therapy [11].and in revised form October 2, 2000
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IL-2 buffer capacity by sIL-2R (sCD25) also has been dialysate was routinely cultured. There were no periods
of contamination, and culture results were ,103 micro-described [10]. Thus, the immunosuppressive state of
HD patients may be due to a deficient cytokine produc- organisms per milliliter. All patients were on subcutane-
ously erythropoietin, depending on their hemoglobintion capacity, an intrinsic T-cell defect, or a disturbed
APC/T-cell interaction as result of biologically active levels. The controls were healthy laboratory personnel
(N 5 11; 5 males, mean age of 35.6 6 9.9 years, se-soluble cytokine receptors or a deficiency in the costimu-
latory pathways. Data on T-cell function in HD patients rum creatinine, ,100 mmol/L). Nondetectable data are
counted as zero.are conflicting. Some authors have mentioned defective
T-cell function, while others have reported normal T-cell
Sample preparationfunction or even activation, depending of the dialyzer
membrane used [7, 8, 12–14]. Previously, we demon- Blood samples were collected in pyrogen-free tubes
containing ethylenediaminetetraacetic acid (EDTA) instrated no differences in mRNA expression for IL-2 in
patients with predialysis end-stage renal failure (ESRF), a final concentration of 1 mg/mL at the start of the HD
procedure. Samples for flow cytometric analysis wereon continuous ambulatory peritoneal dialysis (CAPD)
or HD or in the expression of T-cell activation markers processed immediately after collection. For the isolation
of PBMCs, the buffy coat was diluted in phosphate-(CD25, CD122, HLA-DR) (abstract; van Riemsdijk et
al, Blood Purif 17:222, 1999). To clarify the contribution buffered saline (PBS) solution and layered over a Ficoll-
Isopaque gradient (d 5 1.077). Immediately followingof the cytokines, TNF-a and IL-2, on the compromised
immune state of HD patients, we evaluated both cyto- procurement, 2 3 106 cells were snap frozen in liquid
nitrogen and stored at 2808C for RT-PCR analysis.kine systems in more detail. We measured cytokine
plasma levels, mRNA expression [reverse transcriptase- Plasma was stored at 2808C, and the PBMCs for in vitro
assays were kept in liquid nitrogen.polymerase chain reaction (RT-PCR)], the cytokine
production capacity of peripheral blood mononuclear
mRNA isolation and cDNA reaction and RT-PCRcells [PBMCs; by enzyme-linked immunosorbent assay
(ELISA)], TNF-receptor (CD120b 5 TNF-R2) expres- In PBMCs, we measured mRNA expression levels of
TNF-a, IL-2, and IL-2R (CD25). Procedures for isola-sion on monocytes and lymphocytes, and IL-2Ra (CD25),
IL-2Rb (CD122), and HLA-DR expression on a/b posi- tion of mRNA and reverse transcription into cDNA and
RT-PCR were performed as previously described in detailtive T cells. We performed IL-2 recovery studies to evalu-
ate the biological activity of the sIL-2R (sCD25). In [15]. In brief, total RNA was extracted from snap-frozen
PBMC (2.106), and subsequently, cDNA was synthesizedaddition, we analyzed phytohamagglutinin (PHA)- and
IL-2–induced T-cell proliferation in the HD patients’ with random primers. Aliquots cDNA were directly used
for PCR amplification using sequence-specific primersown (uremic) plasma and performed control experi-
ments in pooled serum, obtained from healthy blood for TNF-a, IL-2, IL-2Ra (CD25), and the housekeeping
gene keratin [16].donors to determine the influence of the uremic environ-
ment on proliferation capacity of PBMCs.
Quantitation of mRNA expression by competitive
template RT-PCR
METHODS
To estimate the relative initial amount of functional
Patients TNF-a and IL-2R (CD25) mRNA in PBMCs, a competi-
tive template RT-PCR assay was used, and a comparisonFifteen patients on HD were evaluated: 8 males, mean
age of 63 6 15 years, serum creatinine, 985 6 169 mmol/L. was made against the housekeeping gene keratin. The
latter gene is assumed to be expressed at a constant levelThe patients were dialyzed two to three times per week
for four to six hours (645 6 112 min/week). A mean in PBMCs. To obtain a standard curve for TNF-a, IL-2R
(CD25), and keratin, known amounts of internal controlKt/V of 1.3 was achieved per dialysis session. The time
on dialysis varied from 8 until 91 months (a mean of 30 fragment were added in different dilutions to constant
amounts of sample cDNA for competitive coamplifica-months). The dialyzer membranes used in the study were
polysulfone (N 5 9; F60 Fresenius, AG, Bad Homburg, tion. The internal control was designed to generate a
PCR product of a smaller size to allow differentiationGermany) and Hemophane (N 5 6; MA-12H; Kawasumi
Laboratory Inc., Minamiohi Shinagawa, Tokyo, Japan). between the amplified target and the internal control.
The relative intensity of internal control and target prod-Both dialyzer membranes belong to the “high-flux”
membranes and are known for their biocompatibility. ucts on gel was measured by luminescence with a DC-40
camera in combination with analysis software (Kodak,Previously, we showed that no differences in the activa-
tion parameters of the TNF-a system were present be- Rochester, NY, USA). Subsequently, the relative con-
centrations of TNF-a and IL-2R (CD25) were dividedtween patients dialyzed with either of the membranes
[11]. All patients were on bicarbonate dialysate. The by the relative concentration of keratin to estimate the
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initial cytokine mRNA expression level in PBMCs. This was 5 to 10%. The detection limit for IL-2R was 16
represents the amount of TNF-a and IL-2R (CD25) U/mL, with a coefficient of variation of 5%. Soluble
mRNA transcripts corrected for the amount of mRNA TNF-receptors R1 and R2 were measured by ELISA
used for reverse transcription and efficacy of each reac- (R&D Systems Europe, Abingdon, UK). The detection
tion. limit was 15 pg/mL for both sTNF-R1 and -R2. To evalu-
ate the biological activity of the sIL-2R in HD, we per-
Flow cytometric analysis formed an IL-2 recovery assay. The test was performed
Whole-blood EDTA samples were monitored for the with two concentrations recombinant human (rh)IL-2:
presence of immune competent cells: monocytes 125 and 500 pg/mL. After 30 minutes of incubation of
(CD141) and lymphocytes (a/b TCR positive). Surface patients and control plasma with a known amount of
activation markers were analyzed by two-color flow cy- rhIL-2, the residual IL-2 level was measured using the
tometry after staining with monoclonal antibodies di- previously mentioned ELISA. The recovery is:
rected to CD14 (Immunotech, Marseille, France), as a
Recovery 5marker for monocytes, and WT31 (Becton Dickinson,
Mountain View, CA, USA), as a marker for the a/b [measured IL-2] 2 [baseline 1 added rhIL-2]
added rhIL-2
3 100%
chain of the T-cell receptor (TCR). In these subsets, IL-
2Ra (CD25), IL-2Rb, (CD122) and HLA-DR (Becton
In vitro stimulation assaysDickinson) and TNF-R2 (CD120b; Immunotech) were
monitored. The antibodies, except CD120b, were di- To test the proliferation response of PBMCs from HD
rectly conjugated to fluorescein isothiocyanate (FITC) patients and controls, we stimulated PBMCs, in vitro,
or phycoerythrin (PE). For CD120b, a two-step staining with phytohemagglutinin M (PHA-M; 1:100, final dilu-
was used. After the first step with CD120b, cells were tion; Difco Laboratories, Detroit, MI, USA) and with
incubated with F(ab)2 goat-anti-rat IgG PE. The staining rhIL-2 (10 ng/mL; Chiron, Amsterdam, The Nether-
procedure was performed by incubating 15 mL 1/100 lands) for three days at 378C in a humidified atmosphere
diluted CD120b antibody with 100 mL blood (30 minutes containing 5% CO2. Proliferation after 3H-thymidine (0.5
at 48C). After washing in Hank’s balanced salt solution mCi/well) incubation for eight hours of culture was mea-
(HBSS; GIBCO, BRL, Paisly, UK) with 0.1% bovine sured. Radioactivity was determined using a Betaplate
serum albumin (BSA; Sigma, St. Louis, MO, USA) and counter (LKB, Bromma, Sweden) and expressed as
0.01% sodium azide (Merck, Darmstadt, Germany), the mean counts per minute (CPMs). All assays were per-
red blood cells were lyzed by FACS Lysing Solution formed in the patients’ own plasma and in pooled serum.
(Becton Dickinson). Samples were centrifugated and Both plasma and pooled serum were heat inactivated.
washed in Cell Pack (TOA, Hamburg, Germany). Flow The pooled sera were obtained from healthy blood do-
cytometric analysis was performed on a FACscan flow nors. Each individual serum, included in the pool, was
cytometer using Cell Quest software (Becton Dickin- tested for the presence of HLA-specific antibodies and in
son). From each tube, 10,000 events in the gate were
a mixed lymphocyte culture (MLC) using three different
measured. In order to compare different flow cytometric
responder-stimulator combinations. The serum is ex-assays in time, we calibrated the flow cytometer using
cluded from the pool if antibodies or inhibitory, thatspecific Calibration Beads (Calibration Beads Quantum
is, stimulatory effects on proliferation are present. To1000; Flow cytometer Standards Corp., San Jose, Puerto
measure the influence of a uremic environment on theRico). Each bead contains a known amount of fluoro-
proliferation capacity, PBMCs obtained from healthychrome. The intensity of the fluorescence is converted
controls were stimulated with PHA or rhIL-2 in pooledto a standard curve by Quick Cal Program for Quantum
healthy and uremic serum derived from HD patients. InBeads (Becton Dickinson). The mean fluorescence is
the culture supernatants, we analyzed the concentrationdenoted as molecular equivalents of soluble fluoro-
of TNF-a, sTNF-R1 and R2, using the previously men-chrome (MESF; Fig. 1).
tioned ELISA procedure.
Enzyme-linked immunosorbent assay
StatisticsTumor necrosis factor-a, IL-2, and IL-2R (CD25) con-
The results are given as mean 6 SD or SEM or mediancentrations were measured by commercially available
with range, whatever is appropriate. A comparison of nor-ELISAs (BioSource International, Inc., Camarillo, CA,
mally distributed variables was addressed by analysis ofUSA, and Immunotech, Diagnostic Product Corpora-
variance (ANOVA). Qualitative RT-PCR (IL-2 mRNA)tion, Los Angeles, CA, USA, respectively). The detec-
results was analyzed by the Fischer’s exact test. Quantita-tion limit for TNF-a was ,0.09 pg/mL, and the coeffi-
tive RT-PCR data (IL-2R mRNA, TNF-a mRNA) andcient of variation was 3.2 to 7.0%. The detection limit
for IL-2 was 5 pg/mL, and the coefficient of variation concentrations of cytokines in peripheral blood were
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Fig. 1. (A) Quantitative flow cytometry. Construction of the standard curve using specific calibration beads, each containing a different known
amount of fluorochrome (upper panel).The amount of fluorochrome is converted by software into fluorescence intensity, denoted as molecular
equivalents of fluorochrome (MESF; lower panel). (B) Typical example of CD120b expression on a/b TCR by quantitative flow cytometry. In the
upper panel, the FITC labeled a/b-positive T cells are in the gate. In the lower panel, the fluorescence intensity of the CD120b positive T cells is
depicted. The mean fluorescence intensity can be extrapolated to the standard curve and is denoted as MESF (A).
compared by Mann-Whitney U-test. P values #0.05 were controls (abstract; van Riemsdijk et al, Blood Purif 16:
247, 1998). The mRNA expression levels of the IL-2Raconsidered significant.
chain (CD25) were also not different in patients and
healthy controls (mean IL-2R/keratin ratio, 22.9 vs. 14.2,
RESULTS P 5 NS; Fig. 2).
mRNA expression of TNF-a and IL-2 by RT-PCR
TNF-a and IL-2 receptor expression on immuneIn PBMCs obtained from patients on HD and healthy
competent cells by quantitative flow cytometrycontrols, we measured the mRNA expression for TNF-a,
The absolute numbers of a/b-positive T cells wereIL-2, and IL-2R (CD25). TNF-a mRNA expression lev-
significantly lower in HD patients compared with healthyels were significantly higher in HD patients than in
controls (mean 664 6 87 versus 979 6 99/mL, P 5 0.03).healthy controls: median TNF/keratin ratio 47541 vs. 604
The absolute numbers of CD141 monocytes were not(P , 0.0001; Fig. 2). In contrast, IL-2 mRNA expression
different in both groups. In patients on HD, the expres-was not less often found in PBMCs from HD patients
sion of the TNF-R2 (CD120b) was significantly enhancedcompared with healthy controls, 6 out of 15 (38%) in
on a/b TCR-positive lymphocytes (mean MESF 5466 6HD versus 9 out of 11 (88%) in controls (P 5 0.34).
892 versus 3151 6 507) as well as on monocytes (meanThese results are in line with our previous study, in
MESF 10233 6 3531 versus 2563 6 808, P 5 0.01 andwhich we could not detect mRNA expression for IL-2
in patients with ESRF, on CAPD or on HD, or in healthy P 5 0.02, respectively). In contrast, the expression of
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Fig. 1. (Continued)
the activation markers on the T-cell surface, CD25 (IL- the T cells obtained from healthy controls (P 5 0.04).
2Ra), CD122 (IL-2Rb), and HLA-DR was comparable The levels of sTNF-R1 were significantly higher in cul-
between HD patients and healthy controls (Fig. 3). ture supernatants of HD PBMCs compared with con-
trol PBMCs [mean sTNF-R1 (after PHA-stimulation),
Soluble TNF and IL-2 receptor levels by ELISA
115.0 6 7.1 ng/mL (corrected for lymphopenia, 172
TNF-a system. Plasma TNF-a protein levels were sig- ng/mL; HD) versus 78.3 6 9.0 ng/mL (controls), P 5
nificantly higher HD patients compared with controls 0.008 (P , 0.0001, corrected)]. After IL-2 stimulation,
(5.6 6 0.9 versus 0.9 6 0.1 pg/mL, P , 0.001). To test the sTNF-R1 levels were 107.4 6 11.0 ng/mL (corrected,
the TNF-a production capacity by T cells, we stimulated
161 ng/mL; HD) versus 74.8 6 6.7 ng/mL (controls), P 5PBMCs with the mitogen PHA. This resulted in signifi-
0.027 (corrected, P , 0.0001). The sTNF-R2 productioncantly lower TNF-a concentrations in supernatants of
after PHA stimulation was not significantly different be-PBMCs from HD patients than in supernatants of
tween patients and controls. IL-2 stimulation resulted inPBMCs from healthy controls (mean TNF-a, 220.6 6
a higher production of sTNF-R2 in supernatants of HD92.9 versus 1012.2 6 341 pg/mL, respectively, P , 0.001).
patients [461.3 6 51.4 ng/mL (corrected, 692 ng/mL)Correction for the lymphopenia in HD patients results
versus 386.6 6 54.2 ng/mL (controls), P 5 0.0005 (afterin a mean TNF-a production of 331 pg/mL, which still
is significantly lower compared with the production of correction for lymphopenia; Table 1)].
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Fig. 2. mRNA expression levels of tumor necrosis factor-a (TNF-a)
and interleukin-2 receptor (IL-2R) by peripheral blood mononuclear
cells (PBMC) in patients on hemodialysis (HD) and healthy controls
measured by reverse transcription-polymerase chain reaction (RT-
PCR). Results are denoted as cytokine/keratin ratio, in which keratin
is the housekeeping gene. Symbols are: ( ) controls; ( ) hemodialysis Fig. 3. Expression of activation markers of IL-2Ra chain (CD25) and
patients. IL-2Rb chain (CD122), HLA-DR on lymphocytes, and TNF-R2
(CD120b) on monocytes and lymphocytes, measured by quantitative
flow cytometry, denoted as MESF (mean 6 SEM). The expression of the
TNF-R2 was significantly higher on both lymphocytes and monocytes of
HD patients (P 5 0.01 and P 5 0.02, respectively). Symbols are: ( )IL-2 system controls; ( ) hemodialysis patients.
In HD patients and controls, baseline plasma IL-2
levels were within the detection limit of the used ELISA
test. In contrast, IL-2R (CD25) levels were significantly
were corrected for the HD-related lymphopenia, washigher in plasma of HD patients (mean 1467 6 230 versus
comparable by PBMCs obtained from healthy controls409 6 13 U/mL, for healthy controls, P , 0.001; Table
and HD patients, regardless of whether the test was2). After three days of PHA stimulation, the IL-2 and
performed in the patient’s own uremic or pooled healthy
sIL-2R (sCD25) production capacity of PBMCs, when
serum (Fig. 4B).
measured in own plasma, was comparable between
Both the PHA- and IL-2–stimulated proliferation of
PBMCs from HD patients and controls. However, when
PBMCs from healthy controls was inhibited in uremic
the assay was performed in pooled serum, the PHA- plasma. The mean relative stimulation index of the PHA-
induced IL-2 production by PBMCs was significantly induced proliferation of healthy PBMCs in normal
higher in HD patients (P 5 0.03). The PHA-induced sIL- plasma was 76 6 9.0 versus 59.0 6 8.0 in uremic plasma
2R production was comparable in both groups (Table 2). (P 5 0.16). The IL-2–induced proliferation resulted in
To obtain an impression of the biological activity of a mean relative stimulation index of 93.5 6 13.3 (normal
the sIL-2R (sCD25), we performed an IL-2 recovery plasma) and 68.0 6 13.4 (uremic plasma; P 5 0.08).
study. In plasma, the IL-2 recovery after the addition of
125 pg/mL rhIL-2 was 55 6 9.4% (HD) versus 43%
DISCUSSION(controls, P 5 0.02), and in the presence of surplus of
rhIL-2 (500 pg/mL), the recovery remained increased in Immunologic function in HD patients is related to the
59.6 6 9.4 versus 49.9 6 8.2%, respectively (P 5 0.05, overall survival in these patients [16]. Cytokines such
Mann–Whitney; Table 2). TNF-a and IL-2 are important in the regulation of the
immune responses. Imbalanced cytokine systems may
Proliferation tests result in ineffective immunologic responses and conse-
Phytohemagglutinin and rhIL-2 stimulation resulted quently lead to high susceptibility for infections, malig-
in a significantly increased proliferation of PBMCs ob- nancies, and decreased responses on T-cell–dependent
tained from HD patients as well as from healthy controls. antigens [1, 2]. In the present study, we measured the
Proliferation assays performed in own plasma showed activity of both the TNF-a and the IL-2 system in patients
comparable proliferation capacity of PBMCs from on chronic HD, on mRNA and protein levels, as well
healthy controls and HD patients, when corrected for the as on membrane-bound and soluble receptor levels. Both
HD-related lymphopenia (P 5 0.07). When performed in systems are of paramount importance in the APC/T-cell
pooled serum, the PBMCs from healthy controls, as well interaction initiating specific immune responses. More-
as from HD patients, had a higher proliferation capacity, over, we performed functional assays to find out whether,
without differences between the two groups (Fig. 4A). in vitro, specific APC/T-cell defects were detectable in
peripheral cells of HD patients.Also, IL-2–induced proliferation capacity, when results
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Table 1. Phytohemagglutinin (PHA) and recombinant human interleukin-2 (rhIL-2; 10 ng/mL)–induced tumor necrosis-a (TNF-a), soluble
TNF receptors 1 and 2 (sTNF-R1 and sTNF-R2) production by peripheral blood mononuclear cells (PBM of C) obtained from hemodialysis
patients and healthy controls, cultured in pooled serum, measured in supernatant after three days of stimulation, by ELISA
Controls Patients Patients’
N 5 11 N 5 15 corrected datac P valuea
TNF-a pg/mL
Day 0 4.8 6 1.2 4.8 6 1.2 NS
PHA 1012.2 6 341b 220.6 6 92.9b 330.9 6 92.9b 0.04
IL-2 31.2 6 8.7 18.2 6 3.4 27.3 6 3.4 NS
sTNF-R1 ng/mL
Day 0 79.0 6 1.4 79.0 6 1.4 NS
PHA 78.3 6 9.0 115.0 6 7.1 172.5 6 1.4 ,0.0001
IL-2 74.8 6 6.7 107.4 6 11.0 161.1 6 11.0 ,0.0001
sTNF-R2 ng/mL
Day 0 88.3 6 1.0 88.3 6 1.0 NS
PHA 540.1 6 94.9b 449.4 6 94.7b 674.1 6 94.7b 0.34
IL-2 386.6 6 54.2b 461.3 6 51.4b 692.0 6 51.4b 0.0005
Data are mean 6 SEM.
aStudent t test
bP , 0.001 versus day 0
c Corrected for hemodialysis-related lymphopenia
Table 2. Plasma levels at t 5 0 (baseline) and the PHA-induced production of IL-2 and sIL-2R by PBMC obtained from healthy controls
and HD patients, measured in supernatant after three days of stimulation, by ELISA
Controls Patients Patients’
N 5 11 N 5 15 corrected dataa P valueb
Baseline
IL-2 pg/mL 9.3 6 3.1 5.0 6 0.0 NS
sIL-2R U/mL 409 6 13 1467 6 230 ,0.001
PHA-induced
IL-2 pg/mL
own 1440 6 217 1956 6 944 2934 6 944 0.19
pooled 2823 6 558 2996 6 482 4494 6 482 0.03
sIL-2R U/mL
own 124 6 33 93 6 15 140 6 15 NS
pooled 99 6 23 86 6 31 129 6 31 NS
IL-2 recovery
1 125 pg rhIL-2 43.1 6 8.4% 55 6 9.4% 0.02
1 500 pg rhIL-2 49.9 6 8.2% 59 6 9.4% 0.05
Tests are performed in own plasma and pooled serum. Data are mean 6 SEM. Abbreviations are in Table 1.
aCorrected for dialysis-related lymphopenia
bStudent t test
The TNF-a system cantly lower after PHA stimulation of PBMCs from HD
patients, in contrast to the IL-2–induced TNF-a. At theIn previous studies, we detected significantly increased
same time, significantly higher concentrations sTNF-R1TNF-a mRNA expression by PBMCs in patients on HD.
and sTNF-R2 were found in the supernatants after stimu-Furthermore, we found high levels of active, soluble
lation, reflecting shedding of their increased receptors.TNF-R, sTNF-R1, and sTNF-R2, which buffered recom-
From these data, we conclude that although PBMCsbinant TNF-a to a large extent [11]. In the present study,
from patients on HD are constantly activated, T cellswe confirmed the activated state of PBMCs by finding
are not able to produce adequate amounts of TNF-asignificantly increased receptor expression of TNF-a,
upon stimulation.TNF-R2 (CD120b) on both lymphocytes and monocytes
Zamauskaite et al also described an impaired TNF-aof patients on chronic HD. Moreover, we were able to
production upon stimulation by T cells, using intracellu-detect significantly higher levels of free plasma TNF-a
lar cytokine staining, but only in patients on peritonealby using the sensitive ELISA kit. To evaluate the TNF-a
dialysis therapy [17]. The overproduction of TNF-a byproduction capacity by T cells, PHA- and IL-2–induced
PBMCs of chronic HD patients reported by Girndt etTNF-a production were measured in vitro. In culture
supernatants, free TNF-a concentrations were signifi- al is not contradictory to our results, as they induced
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dialyzer membranes is provided. It appeared from this
study that patients dialyzed with a polysulfone mem-
brane (PS) have cytokine profiles highly comparable to
healthy controls [23]. Our in vitro data align with these
findings. At both mRNA and protein levels, we mea-
sured comparable production of IL-2 between HD pa-
tients (dialyzed with PS and Hemophane membranes)
and healthy controls. Also, expression of the a-chain
(CD25) and b-chain (CD122) of the IL-2R complex was
not increased on T cells in these HD patients. In previous
work, we have demonstrated no differences in T-cell
activation markers at the single cell level in patients with
ESRF, on CAPD and HD, using the quantitative flow
cytometric analysis. Thus, no overt indication for an in-
trinsic deficient IL-2 system was established. However,
significantly higher levels of sIL-2R (sCD25) were pres-
ent in plasma from HD patients. These high levels of
sIL-2R did bind up to 55% of rhIL-2, suggestive for an
impaired biological availability of the IL-2 produced.
Proliferation tests
In peripheral blood of patients on HD, we found a
significantly lower number of a/b-positive T cells. To
evaluate the functional capacity of these T cells, we mea-
sured the PHA-stimulated proliferation capacity. This
Fig. 4. Proliferation capacity [counts per minute (CPM)] of PBMCs proliferation capacity of T cells from patients on HD
from patients on HD and healthy controls, performed in own plasma and appeared to be significantly decreased compared withpooled serum, after stimulation with mitogen PHA (A) or recombinant
control T cells. These results are in line with Krishnamur-human IL-2 (10 ng/mL; B, mean 6 SEM). Symbols are: ( ) controls;
( ) hemodialysis patients; ( ) corrected HD. thy et al, Raskova et al, and Severini et al [22, 24, 25].
However, when we corrected the data for the overt lym-
phopenia found in HD patients, no statistically signifi-
cant differences were present in the proliferation capac-mononuclear cells with lipopolysaccharide, which stimu-
ity of T cells. The influence of uremic environment waslates monocytes rather than T cells [12].
determined by comparing the proliferative capacity of
PBMCs obtained from healthy controls in uremic andThe IL-2 system
pooled plasma. This capacity for proliferation signifi-
Chatenoud et al suggested that the immunosuppres- cantly decreased in uremic plasma, thereby confirming
sive state of HD patients was due to a deficient IL-2 the data of Donati et al and Severini et al, who studied
system [18]. However, conflicting data concerning pa- the effect of uremic serum on PHA stimulated prolifera-
rameters of the IL-2 system in patients with ESRF, on tive responses of healthy PBMCs and purified T-cell
CAPD or HD, are present. Weinstein et al and Caruana subpopulations [25, 26]. The presence of a continuously
et al reported increased levels of IL-2 in patients with activated TNF-a system and an inadequate TNF-a pro-
ESRF and HD, while in patients on CAPD, increased duction upon stimulation suggests tachyphylaxis of T
as well as normal levels of IL-2 are found, all compared cells. The IL-2 system seemed not intrinsically affected
with healthy controls [19, 20]. Ha et al and Krishnamur- as T cells were able to proliferate normally upon IL-2
thy, Kher, and Naik demonstrated lower levels of IL-2 stimulation. Like the present study, others have also
and a decreased lower IL-2 production in ESRF and HD attempted to link the TNF-a and IL-2 system [27]. Owen-
patients [21, 22]. Rostaing et al describes the intracyto- Schaub et al correlated the expression of TNF-R on
plasmatic expression of various cytokines, that is, IL-2, lymphocytes to IL-2 production [28]. According to these
IL-6, interferon-g, and TNF-a, in relationship to differ- authors, increased TNF-R expression indicated T-cell
ent dialyzer membranes and compared the results to activation, whereas we assume that elevated TNF-R ex-
patients with predialysis ESRF and healthy controls [23]. pression is independent of T-cell activation. Some publi-
By measuring the cytokines, intracytoplasmatic difficul- cations described intrinsic T-cell dysfunction [29], while
ties in assessment of plasma cytokine levels are pre- others reported normal T-cell function [14, 30]. T-cell
dysfunction may be induced by the HD procedurevented and more insight in the influence of the various
van Riemsdijk et al: Tachyphylaxis and TNF-a 891
activation markers of T cells, B cells, and monocytes. J Immunol[31–34] or result from monocyte dysfunction [9]. Our
154:882–892, 1995
data are in line with Kelly, Degiannis et al, and Modai 3. Braun N, Rosenfeld S, Giolai M, et al: Effect of continuous
hemodiafiltration on IL-6, TNF-alpha, C3a, and TCC in patientset al [8, 14, 35]: it is an intact T-cell function but disturbed
with SIRS/septic shock using two different membranes. ContribAPC function, for example, TNF-a production. Addi-
Nephrol 116:89–98, 1995
tional dose–response studies on cytokine-induced prolif- 4. Brunet P, Capo C, Dellacasagrande J, et al: IL-10 synthesis and
secretion by peripheral blood mononuclear cells in haemodialysiseration of normal T cells in uremic plasma in the pres-
patients. Nephrol Dial Transplant 13:1745–1751, 1998ence of antibodies against various immunoreactants
5. Roccatello D, Menegatti E, Alfieri V, et al: Intradialytic cyto-
could provide further evidence for our hypothesis. kine gene expression. Blood Purif 16:30–36, 1998
6. Roccatello D, D’Alfonso S, Peruccio D, et al: Induction ofThe results of this study can be influenced by the
mRNA for tumor necrosis factor alpha in hemodialysis. Kidneysignificantly older age of the HD patients compared with Int 43(Suppl 39):S144–S148, 1993
the age of the healthy controls (P , 0.001). Many authors 7. Donati D, Degiannis D, Raskova J, et al: Uremic serum effects
on peripheral blood mononuclear cell and purified T lymphocytehave described the influence of aging on cytokine levels
responses. Kidney Int 42:681–689, 1992and production. However, data on cytokine levels and 8. Kelly CJ: T cell function in chronic renal failure and dialysis.
production are not consistent. Concerning the proin- Blood Purif 12:36–41, 1994
9. Bazzoni F, Beutler B: The tumor necrosis factor ligand andflammatory cytokines, IL-1b, IL-6 and TNF-a, increased
receptor families. N Engl J Med 334:1717–1725, 1996
[36–38] as well as decreased [39, 40] in the older popula- 10. Hory B, Racadot E, Saint-Hillier Y, et al: Soluble interleukin-
2 receptors in chronic renal failure. Am J Nephrol 11:276–280,tion are found. Bruunsgaard et al found lower levels of
1991IL-1b and TNF-a in healthy old people (age of 81 years)
11. van Riemsdijk I, Baan CC, Hesse CJ, et al: TNF-alpha: mRNA,
when the results of young men were compared (age of plasma protein levels and soluble receptors in patients on chronic
hemodialysis, on CAPD and with end-stage renal failure. Clin19 to 31 years); however, these differences disappeared
Nephrol 53:115–123, 2000when compared with the results of the older to that
12. Girndt M, Kohler H, Schiedhelm-Weick E, et al: T cell activation
of younger women [39]. The same conflicting data are defect in hemodialysis patients: Evidence for a role of the B7/
CD28 pathway. Kidney Int 44:359–365, 1993described for IL-2, IL-4, IL-8, and interferon-g [36, 38,
13. Kohler H, Girndt M, Dumann H, et al: The immune defect in40–42]. In our study, the HD patients are significantly kidney failure. II. The mechanisms of the “uremic” immune defect.
older compared with the healthy controls. Their mean Dtsch Med Wochenschr 118:790–795, 1993
14. Degiannis D, Czarnecki M, Donati D, et al: Normal T lymphocyteage of 63 years, however, in the literature concerning
function in patients with end-stage renal disease hemodialyzed
about cytokine and aging, is not regarded as old (in most with ‘high-flux’ polysulfone membranes. Am J Nephrol 10:276–282,
1990studies, old age is 80 years and older). The authors do
15. van Riemsdijk IC, Baan CC, Niesters HG, et al: The TNF-alphanot think that the differences in the studied parameters
system in heart failure and after heart transplantation: Plasma
of the TNF-a and IL-2 system are influenced by the protein levels, mRNA expression, soluble receptors and plasma
buffer capacity. Eur Heart J 20:833–840, 1999older age of the HD patients.
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